Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Income from Continuing Operations (2016 - 2025)

Macrogenics (MGNX) has disclosed Income from Continuing Operations for 14 consecutive years, with 14127000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 2.42% to 14127000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 77685000.0, a 9.67% decrease, with the full-year FY2025 number at 74592000.0, down 11.39% from a year prior.
  • Income from Continuing Operations was 14127000.0 for Q4 2025 at Macrogenics, down from 16822000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 54191000.0 in Q3 2024 to a low of 66638000.0 in Q1 2022.
  • A 5-year average of 32120250.0 and a median of 41043500.0 in 2021 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: crashed 2583.69% in 2021, then soared 252.64% in 2024.
  • Macrogenics' Income from Continuing Operations stood at 58236000.0 in 2021, then skyrocketed by 120.58% to 11983000.0 in 2022, then tumbled by 511.87% to 49354000.0 in 2023, then surged by 70.67% to 14477000.0 in 2024, then increased by 2.42% to 14127000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Income from Continuing Operations are 14127000.0 (Q4 2025), 16822000.0 (Q3 2025), and 37665000.0 (Q2 2025).